Neurotoxicity of carbonyl sulfide in F344 rats following inhalation exposure for up to 12 weeks
-
Upload
daniel-l-morgan -
Category
Documents
-
view
214 -
download
1
Transcript of Neurotoxicity of carbonyl sulfide in F344 rats following inhalation exposure for up to 12 weeks
www.elsevier.com/locate/ytaap
Toxicology and Applied Pharmacology 200 (2004) 131–145
Neurotoxicity of carbonyl sulfide in F344 rats following inhalation
exposure for up to 12 weeks
Daniel L. Morgan,a Peter B. Little,b David W. Herr,c Virginia C. Moser,c Bradley Collins,d
Ronald Herbert,e G. Allan Johnson,f Robert R. Maronpot,e G. Jean Harry,a and Robert C. Sillse,*
aLaboratory of Molecular Toxicology, NIEHS, Research Triangle Park, NC 27709, USAbPathology Associates Division of Charles River Laboratories, Durham, NC 27713, USA
cNeurotoxicology Division, U.S. Environmental Protection Agency, Research Triangle Park, NC 27511, USAdLaboratory of Pharmacology and Chemistry, NIEHS, Research Triangle Park, NC 27709, USA
eLaboratory of Experimental Pathology, NIEHS, Research Triangle Park, NC 27709, USAfDuke University Medical Center, Durham, NC 27710, USA
Received 20 January 2004; accepted 12 April 2004
Available online 20 July 2004
Abstract
Carbonyl sulfide (COS), a high-priority Clean Air Act chemical, was evaluated for neurotoxicity in short-term studies. F344 rats were
exposed to 75–600 ppm COS 6 h per day, 5 days per week for up to 12 weeks. In rats exposed to 500 or 600 ppm for up to 4 days, malacia
and microgliosis were detected in numerous neuroanatomical regions of the brain by conventional optical microscopy and magnetic
resonance microscopy (MRM). After a 2-week exposure to 400 ppm, rats were evaluated using a functional observational battery. Slight gait
abnormality was detected in 50% of the rats and hypotonia was present in all rats exposed to COS. Decreases in motor activity, and forelimb
and hindlimb grip strength were also detected. In rats exposed to 400 ppm for 12 weeks, predominant lesions were in the parietal cortex area
1 (necrosis) and posterior colliculus (neuronal loss, microgliosis, hemorrhage), and occasional necrosis was present in the putamen, thalamus,
and anterior olivary nucleus. Carbonyl sulfide specifically targeted the auditory system including the olivary nucleus, nucleus of the lateral
lemniscus, and posterior colliculus. Consistent with these findings were alterations in the amplitude of the brainstem auditory evoked
responses (BAER) for peaks N3, P4, N4, and N5 that represented changes in auditory transmission between the anterior olivary nucleus to the
medial geniculate nucleus in animals after exposure for 2 weeks to 400 ppm COS. A concentration-related decrease in cytochrome oxidase
activity was detected in the posterior colliculus and parietal cortex of exposed rats as early as 3 weeks. Cytochrome oxidase activity was
significantly decreased at COS concentrations that did not cause detectable lesions, suggesting that disruption of the mitochondrial
respiratory chain may precede these brain lesions. Our studies demonstrate that this environmental air contaminant has the potential to cause a
wide spectrum of brain lesions that are dependent on the degree and duration of exposure.
D 2004 Elsevier Inc. All rights reserved.
Keywords: Carbonyl sulfide; Neurotoxicity; Magnetic resonance microscopy; Auditory system; Brainstem auditory evoked responses; Cytochrome oxidase
Introduction sources of COS include its use as an intermediate in the
Carbonyl sulfide (COS) is a by-product of coal hydroge-
nation and gasification, viscose rayon production (Houben-
Weyl, 1955), is a component of cigarette smoke (Wynder and
Hoffmann, 1967), and has been identified as a potentially
toxic component of air pollution. The largest man made
0041-008X/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.taap.2004.04.013
* Corresponding author. Laboratory of Experimental Pathology,
National Institute of Environmental Health Sciences, 111 Alexander Drive,
South Campus, MD B3-08, P.O. Box 12233, Research Triangle Park, NC
27709. Fax: +1-919-541-4714.
E-mail address: [email protected] (R.C. Sills).
production of thiocarbamate herbicides and pesticides (EPA,
1994). It is also released as a combustion by-product from
automobile exhaust and in the manufacture of petroleum and
rubber products (EPA, 1994). The atmospheric half-life of
COS is estimated to be 2 years. Carbonyl sulfide was placed
on the list of Clean Air Act Chemicals—Hazardous Air
Pollutants because of reported high emissions (9500 tons per
year). Carbonyl sulfide is a metabolite of carbon disulfide, a
known neurotoxicant (Beauchamp et al., 1983). Although
total COS environmental emissions are relatively high, there
is a lack of toxicity data for this chemical.
D.L. Morgan et al. / Toxicology and Applied Pharmacology 200 (2004) 131–145132
The major concern regarding COS toxicity is potential
neurotoxicity. In an earlier study (Monsanto, 1985),
Sprague–Dawley rats received a 4-h exposure to 1062–
1189 ppm COS. Central nervous system dysfunction was
reported 14 days after exposure. In another study (Nutt et
al., 1996), F344 rats exposed for 4 h to 750–1000 ppm COS
and held for 14 days had vacuolation of the myelin sheath in
the cerebellar peduncles, corpus collosum, and pyramidal
tracts, while rats exposed to 500–590 ppm COS and held
for 3–14 days had focal necrosis or gliosis of the cerebellar
cortex and peduncles.
Based on the limited neurotoxicological and neuropath-
ological evaluation in the peer-reviewed literature, COS was
selected for further toxicological evaluation in the current
study. The objectives of this study were to examine the
neurobehavioral effects of COS exposure and characterize
the cellular responses by light microscopy; evaluate the
neuroanatomical targets by magnetic resonance microscopy
(MRM); characterize the early electrophysiological and
biochemical effects of COS toxicity; and determine the
dose-response relationships of subchronic exposure to COS.
Methods
Range-finding study. Because of the paucity of exposure
data available for COS, a range-finding experiment was
conducted. Male F344 rats (5 per concentration) were
exposed to 0, 75, 150, 300, or 600 ppm COS, 6 h per day
for 4 days. In an attempt to replicate an earlier study (Nutt et
al., 1996), a second group of male rats (5 per concentration)
was exposed to 0, 75, 150, 300, or 600 ppm for 6 h and then
held for 2 weeks without exposure. Rats were anesthetized
(Nembutal, ip), cardiac perfused, and brains were removed
and processed for histological evaluation. Brains were
embedded in paraffin, sectioned at approximately 5 Am,
stained with hematoxylin and eosin (H&E), and evaluated
microscopically.
Two-week repeated exposure. Based upon initial range-
finding results, a 2-week experiment was conducted to
evaluate the effects of repeated exposure to 0, 300, 400,
or 500 ppm COS. Male and female rats (10 per sex per
concentration) were exposed for 6 h per day, 5 days per
week for 12 exposures. Neurobehavioral evaluations were
conducted using a functional observational battery (FOB)
and an automated assessment of motor activity. For the 2-
week study, rats were tested 2 days before COS exposure
(FOB and motor activity), immediately after the first expo-
sure (FOB only), and the morning following the last
exposure (FOB and motor activity). After conducting the
FOB, all rats were anesthetized (Nembutal, ip), cardiac
perfused, and tissues collected for histopathology evalua-
tion. Brains were embedded in paraffin, sectioned at ap-
proximately 5 Am, stained with H&E, and evaluated
microscopically.
Twelve-week exposure. Based upon the results of the 2-
week exposure, a 12-week study was performed at concen-
trations that were not acutely toxic. Male and female F344
rats (20 per sex per concentration) were exposed to 200,
300, or 400 ppm COS 6 h per day, 5 days per week for 12
weeks. Controls were exposed to filtered, conditioned air.
For the 12-week exposure, rats were tested with the FOB
(no motor activity) during the sixth week of exposure
(immediately following exposure) and the morning after
the last exposure. As before, rats were euthanized for
neuropathology after FOB testing. Additional groups of rats
were included for clinical pathology, electrophysiological
testing, magnetic resonance microscopy (MRM), and cyto-
chrome oxidase analyses (see below).
Chemical. Carbonyl sulfide (CAS# 463-58-1) was pur-
chased from Tex-La Gases (Houston, TX). Carbonyl sulfide
was procured as a liquid in gas cylinders equipped with
valves configured to provide the vapor phase of COS.
Chemical purity was determined to be >98.1% by gas
chromatography/thermal conductivity analysis of the vapor
phase over the liquid COS. The 1.9% residual was com-
posed primarily of CO2 with <0.6% H2S. After dilution of
the bulk gas to the desired COS exposure concentrations,
the H2S concentrations were reduced to insignificant levels.
No H2S could be detected in air samples collected from the
chambers during COS exposures.
Inhalation exposure. The COS vapor, at reduced pressure,
was supplied to three variable speed pumps that controlled
the vapor flow necessary to achieve the desired concentra-
tion for each exposure chamber. The COS vapor was mixed
with conditioned air (HEPA filtered, charcoal scrubbed,
temperature and humidity controlled) and delivered to the
Hazleton 2000 exposure chambers at approximately 400 L
min�1. The COS concentration in each chamber was sam-
pled at about 90-s intervals and measured using Orbital
Scientific Model Diamond 20 Fourier transform infrared
(FTIR) spectrophotometers. Exhaust from the exposure
chambers was passed through three activated charcoal
scrubbers (Safemod model CA-500) connected in series.
The scrubbed exhaust was sampled about every 15 min and
analyzed for COS. The concentrations of COS in the
exposure chambers were independently verified before and
during the animal exposures. Chamber samples were ana-
lyzed by gas chromatography (GC) with photo-ionization
and GC-thermal conductivity detectors.
Animals. Male and female Fischer 344 rats (Charles River
Laboratories, Raleigh, NC), 6–7 weeks old on arrival, were
held for 10–14 days to confirm absence of disease and to
acclimate to the exposure facility. During the holding period,
rats were weighed and randomized to treatment groups.
Animals were placed in exposure chambers without food 6
h per day for 2 days before chemical exposure for acclimation
to the exposure conditions. Animals were 8–9 weeks old at
D.L. Morgan et al. / Toxicology and Applied Pharmacology 200 (2004) 131–145 133
the start of the exposures. Animals were individually housed
in Hazleton 2000 inhalation exposure chambers for the
duration of the study. Feed (NIH-07) was removed during
the 6-h exposures and for 6 h per day on nonexposure days.
Water (chlorinated, city water) was provided ad libitum by an
automatic watering system during the nonexposure as well as
the exposure periods. Individual body weights were recorded
for all animals on the day before the first exposure andweekly
thereafter. Rats were observed for clinical signs of toxicity
two times daily (once in the early morning and once in the late
afternoon). Individual animal clinical observations were
documented for all rats at the time of weighing. Animals
were exposed to COS for 6 h per day (approximately 7 AM to
1 PM), 5 days per week (weekends excluded) for up to 12
weeks. All animals were exposed for two consecutive days
before termination. Control animals breathed filtered, condi-
tioned air.
This study was conducted under federal guidelines for
the use and care of laboratory animals and was approved by
the NIEHS Animal Care and Use Committee. Animals
were housed in a humidity- and temperature-controlled,
HEPA-filtered, mass air displacement room in facilities
accredited by the American Association for Accreditation
of Laboratory Animal Care. Animal rooms were maintained
with a light–dark cycle of 12 h (light from 0700 to 1900
h). Sentinel animals, housed in the animal facility as part of
an ongoing surveillance program for parasitic, bacterial,
and viral infections, were pathogen-free throughout the
study.
Functional observational battery (FOB). Behavioral and
neurological changes were assessed using the FOB and an
evaluation of motor activity. The FOB protocol used in this
study was based on previously reported procedural details
and scoring criteria (McDaniel and Moser, 1993). Upon
removal from the cage, the observer ranked the rat’s
reactivity to being held, and in addition noted and ranked
any changes in general appearance, including lacrimation,
salivation, ptosis, pupil size, and piloerection. Next, the rat
was placed on top of a laboratory cart (open field) for 2
min of undisturbed observations of activity level, arousal,
posture, gait, and occurrence of involuntary motor move-
ments (e.g., tremors, convulsions). Next, a series of reflex
tests was conducted that consisted of ranking each rat’s
responses to an auditory click stimulus using a metal
clicker (click response), a pinch on the tail using forceps
(tail-pinch response), and the ability of the pupil to
constrict to a penlight stimulus (pupil response). Aerial
righting was assessed by ranking the ability of the rat to
land on all four feet when dropped from a supine position
30 cm above a padded surface. Forelimb and hindlimb grip
strength were quantified using strain gauges and the force
necessary to break the rat’s grip was recorded. Landing
foot splay, the distance between the hindpaws when
dropped from 30 cm, was conducted last. The same
observer conducted all tests and was blind with respect
to the concentration levels. Motor activity testing was
conducted using photocell-based chambers. The activity
system consists of frames made to fit around a standard
rat cage, with seven photocells evenly spaced across the
length of the cage to detect movement. The activity session
lasted for 30 min.
Clinical pathology. On the morning after the last exposure
(12 weeks), 5 rats per sex per concentration were anesthe-
tized (Nembutal, ip) and blood was collected by cardiac
puncture. Blood samples were centrifuged in serum collec-
tion vials at 500 � g for 10 min. Serum samples were
analyzed for alanine aminotransferase (ALT), alkaline phos-
phatase (AP), aspartate aminotransferase (AST), cholesterol,
sorbitol dehydrogenase (SDH), total protein, creatine kinase
(CK), creatinine, urea nitrogen (UN), and glucose using an
automated analyzer (Monarch System 2000, Instrumenta-
tion Laboratory, Lexington, MA) and commercially avail-
able reagents.
Histopathology. Immediately following FOB evaluations
at the end of the COS exposures, animals were anesthetized
(Nembutal, ip) and perfused via the left ventricle with an
initial flushing solution of 0.9% sodium chloride containing
1000 units/L heparin sodium and 1 ml/L of 1% sodium
nitrite (approximately 1 min) followed by McDowell–
Trump’s fixative (McDowell and Trump, 1976) at a rate
of approximately 30 ml/min for 10–15 min. Pressure was
by gravity from approximately 1 m above the table level.
The brain and other tissues were harvested and placed into
perfusate. Using ventral topographic markers, perpendicu-
lar transverse (coronal) sections of the brain were prepared
from the following six regions: (1) frontal cortex through
the chiasma, (2) frontoparietal cortex through the infundib-
ulum, (3) mid-anterior colliculi, (4) posterior colliculi at the
level just anterior to the pons, (5) cerebellum and medulla
at its midpoint through the cochlear nuclei, and (6) obex at
the posterior medulla at the origin of the spinal central
canal. Brain sections were embedded in paraffin, sectioned
at approximately 5 Am, and stained with hematoxylin and
eosin (H&E). All sections were evaluated by a board-
certified veterinary pathologist with expertise in evaluating
the central and peripheral nervous systems.
Brainstem auditory evoked potentials. A preliminary as-
sessment of electrophysiological changes resulting from the
neuropathology in the brainstem in a subset of animals in
the 12-week study was made after 2 weeks exposure to
COS. Groups (n = 10 per group) of male animals exposed to
0 or 400 ppm COS were removed from the chambers after
10 exposures for brainstem auditory evoked response
(BAER) testing. The BAER was used as a measure of the
auditory neural function of the rats. The BAER is an
electrophysiological response to auditory stimuli and repre-
sents neural transmission from the auditory nerve through
the level of the brainstem (Hall, 1992). Two days after the
Table 1
Incidence of neuropathological lesions in male rats exposed to 600 ppm
COS
CNS regiona Neuropathological Duration
lesionsControl 1 dayb 2 daysc
Brain lesions n = 5 n = 5 n = 5
Parietal cortex area 1 Cortical necrosis 0/5 0/5d 5/5*
Restrosplenial cortex Cortical necrosis 0/5 0/5 2/5
Putamen Necrosis 0/5 1/5 0/5
Internal capsule Necrosis 0/5 2/5 0/5
Thalamus Necrosis 0/5 2/5 5/5**
Pyriform cortex Necrosis 0/5 0/5 2/5
Red nucleus Vacuolation 0/5 0/5 2/5
Anterior
olivary nucleus
Vacuolation
and/or necrosis,
axonopathy
0/5 1/5 3/4*
Posterior colliculus Necrosis 0/5 0/5 5/5**
Cerebellar cortex Necrosis 0/5 1/4 0/5
Cerebellar
roof nucleus
Vacuolation
and/or hemorrhage
0/5 0/4 3/4*
Cerebellar
roof nucleus
Necrosis and
cavitation
0/5 3/3* 0/4
Cerebellar
medullary white
Vacuolation 0/5 5/5** 0/5
Fifth cranial
nerve tract
Vacuolation 0/5 5/5** 0/5
a Thirty-six specific-named areas of brain were recorded in the delta sheets
of six standard sections of brain.b Male rats exposed to COS for 1 day and then held of 14 days.c Male rat exposed to COS for 2 days and sacrificed.d Number of animals with the lesion/number of animals for which that area
of brain was examined.
*P < 0.05 vs. controls (Fisher’s exact test).
**P < 0.001 vs. controls (Fisher’s exact test).
D.L. Morgan et al. / Toxicology and Applied Pharmacology 200 (2004) 131–145134
10th exposure, animals were surgically implanted with
electrodes using procedures that have been described pre-
viously (Herr and Boyes, 1997; Herr et al., 1992, 1994).
Electrode locations were as follows: (1) the active electrode
for BAERs was 3 mm posterior to lambda on the midline,
(2) a ground electrode was 2 mm anterior to bregma and 2
mm to the left of midline, and (3) a reference electrode was
7 mm anterior to bregma and 2 mm to the right of midline.
The rats were allowed to recover approximately 9 days
before testing. Auditory stimuli were calibrated, generated,
presented, and the BAERs were recorded using the system
previously described (Hamm et al., 2000; Herr et al., 1996).
Each subject’s BAER waveform was the average of the
neural responses to 500 stimuli. The auditory stimuli con-
sisted of rarefaction clicks (50 As) at an intensity of
approximately 80 dBpeak SPL (re: 20 APa). The speaker
was placed approximately 10.7 cm in front of, and 26 cm
above, the animal’s auditory canals. This resulted in a
distance of about 28.1 cm between the speaker and the
auditory canals, at an angle of approximately 68j. The
acoustic travel time was approximately 839 As. Due to the
known influence of temperature on evoked potentials (de
Jesus et al., 1973; Hetzler and Dyer, 1984; Hetzler et al.,
1988; Janssen et al., 1991; Miyoshi and Goto, 1973;
Petajan, 1968), colonic temperature was quantified imme-
diately following the animal’s removal from the test cham-
ber. A temperature probe (Model RET-1; Physitemp
Instruments, Inc., Clifton, NJ), connected to a thermometer
(Model BAT-10, Physitemp Instruments, Inc.), was inserted
approximately 8 cm rectally and deep colonic temperature
was recorded. These data were used to ascertain if changes
in body temperature could be related to alterations in
evoked potentials.
Peak amplitudes and latencies were measured from each
animal’s average waveform. Peak amplitudes (in AV) weremeasured from baseline (defined as the average voltage over
the prestimulus period). Peak latencies (in ms) were calcu-
lated from stimulus onset. Peaks were identified by their
polarity and latency according to the average waveform
from each treatment group. Data were analyzed using an
analysis of variance (ANOVA; PROC GLM) (SAS Institute,
1989, 1997) with the concentration of COS treated as a
between-subject factor. A critical a level of V0.05 was used
for all analysis in this exploratory study. Data are reported as
mean F SE. Group-averaged waveforms were calculated
from individual animal data and are presented for illustrative
purposes.
Cytochrome C oxidase assay. In initial studies (Nutt et al.,
1996), there was some suggestion that COS may inhibit
mitochondrial enzymes. To further explore potential mech-
anisms of COS neurotoxicity, the rate-limiting enzyme in
the mitochondrial respiratory chain (cytochrome c oxidase)
was evaluated in the current study. Our hypothesis is that
COS inhibits mitochondrial enzymes in the areas of the
brain with high energy requirements.
After exposure for 3, 6, and 12 weeks, 5 rats per sex per
exposure concentration were euthanized (Nembutal, ip) and
the brains rapidly removed and flash frozen in liquid nitro-
gen. Regions approximating the parietal cortex and posterior
colliculus were dissected from frozen brains. The reported
method (Dorman et al., 2002) was modified to prepare the
frozen brain sections for the cytochrome oxidase assay.
Portions (approximately 50 mg) of the posterior colliculus
and parietal cortex were homogenized in 15 ml of ice-cold 10
mM HEPES buffer (pH 7.4, 50 mM sucrose, 200 mM
mannitol, 1 mM EDTA). The homogenate was centrifuged
for 10 min at 3000� g at 4 jC. The pellet was discarded andthe supernatant used for the cytochrome oxidase assay.
Cytochrome oxidase activity was determined by the
reported method (Hess and Pope, 1963) and adapted for
use in a microplate reader (Bio-Tek, EL-340). A stock
solution of 0.25 mM cytochrome c was prepared in 50
mM HEPES buffer and stored for up to 1 week at 4 jC.Working concentrations of reduced cytochrome c (0.025
mM) were prepared daily in the same buffer and reduced
by adding sodium hydrosulfite up to 1 AM. Excess hydro-
sulfite was oxidized by shaking the solution for 3 min. The
degree of reduction was evaluated by measuring the ratio of
absorbance (Beckman DU640 spectrophotometer) at 550–
Fig. 1. Male F344 rats were exposed to 600 ppm carbonyl sulfide (COS) for 1 day (6 h) and held for 2weeks. Themagnification of all figures represents the original
magnification (objective � zoom lens) at the time of photomicroscopy. (A) Bilateral symmetrical areas of necrosis and microgliosis in the internal capsule
(arrows), H&E, 3.3�. (B) Focal necrosis with cavitation of the cerebellar white matter, granular layer, andmolecular layer (arrow), H&E, 8�. (C)Multifocal areas
of necrosis and gliosis in cerebellar roof nuclei (arrows), H&E, 2.5�. (D) Gliosis is characterized by accumulations of microglial cells and macrophages within an
area of malacia, H&E, 40�.
Fig. 2. Male F344 rats were exposed to 600 ppm carbonyl sulfide (COS) for 2 days (6 h per day). (A) Note the predominant bilateral symmetrical necrosis in area 1
of the parietal cortex (arrow head), in the thalamus (arrows) and within the retrosplenial granular cortex, H&E, 2.5�. (B) Similar bilateral symmetrical necrosis is
seen in the posterior colliculi (arrows), H&E, 2.5�. (C) Higher magnification of parietal cortex area 1. The extensive area of necrosis is characterized by
microvacuolation of the neuropil especially at the periphery (arrows) and the presence of mutifocal hemorrhage (arrowheads), H&E, 13.2�. (D) Compared to the
adjacent normal parietal cortex (N), neurons in the area of necrosis are shrunken and basophilic (arrows). The lesion is morphologically early in type, H&E, 50�.
D.L. Morgan et al. / Toxicology and Applied Pharmacology 200 (2004) 131–145 135
D.L. Morgan et al. / Toxicology and Applied Pharmacology 200 (2004) 131–145136
565 nm (Dorman et al., 2002). Working solutions prepared
by this method consistently yielded measured ratios greater
than 6.5. The supernatant was diluted 10-fold in 10 mM
HEPES buffer and 10 Al was added to 200 Al of reducedcytochrome c solution. Enzyme activity was measured by
following the decrease in absorbance at 550 nm every 15 s
for 30 measurements.
The total protein in each supernatant sample was mea-
sured by modifying the Bradford assay (Sigma, St. Louis,
MO) for use in the microplate reader. Bovine serum albumin
standards were prepared to encompass the range of 0.095–
1.5 mg/ml. Ten microliters of undiluted supernatant or
standard was added to 200 Al of Bradford reagent, incubated
at room temperature for 5 min, and the absorbance was read
at 595 nm.
Magnetic resonance microscopy (MRM). A preliminary
MRM study was conducted in parallel with the 12-week
study based on the findings (Nutt et al., 1996) that
indicated the brain was a potential target for COS neuro-
toxicity. The rationale for including MRM in the study is
that it is the imaging modality of choice for identifying
changes in neuroanatomical structures, and 200 brain slices
can be evaluated without destroying the brain. F344 rats
were exposed to 0 or 400 ppm COS during the 12-week
studies.
Before MR imaging, rats were anesthetized and cardiac
perfused with McDowell Trump’s fixative containing
gadolinium MR contrast agent. The brains were removed
and the fixed specimens were scanned at 9.4 T using spin
echo encoding (TR = 100 ms, TE = 3.2 ms) for 3.5 h.
The scans provided a 256 � 256 � 256 image array with
a resolution of 70 � 70 � 140 Am (7 � 10�4 mm3).
Details of MRM methods have been published previously
(Johnson et al., 2002). After the images were analyzed,
the fixed whole brains were placed in neutral-buffered
formalin. Abnormal findings identified in the MRM
images provided a guide for determining where brain
sections were going to be made for subsequent histolog-
ical evaluation (Sills et al., 2004).
Table 2
Body weight of F344 rats exposed to COS for 2 weeks
COS Males Females
(ppm)Numbers of exposure Numbers of exposure
0 5 12 0 5 12
0 222 F 12a 235 F10 252 F 11 155 F 3 160 F 4 164 F 6
300 219 F 15 229 F 11 248 F 11 160 F 2 163 F 4 168 F 3
400 221 F 14 231 F 14 243 F 16 158 F 5 160 F 2 162 F 4
500 218 F 15 202 F 14* b 157 F 3 145 F 9* 159 F 6c
a Values are in grams and represent means F SD, n = 10.b No survivors.c N = 6 rats.
*Significantly less than control P < 0.05.
Results
Range-finding experiment
Clinical observations
No mortality, morbidity, or clinical signs of toxicity
were observed in rats exposed to 75, 150, or 300 ppm
COS for 4 days. However, some rats exposed to 600 ppm
were euthanized in moribund condition after 2 days of
exposure. Animals exposed to 600 ppm exhibited clinical
signs of hypothermia, lethargy, ataxia, and impaired right-
ing reflex.
No mortality occurred in rats that received one 6-h expo-
sure to 75, 150, 300, or 600 ppm COS and were then held
for 2 weeks. Animals exposed to 600 ppm were lethargic
when observed immediately after exposure and the follow-
ing morning (day 2). By the afternoon of day 2, these rats
exhibited clinical signs of hypothermia, lethargy, head tilt,
and ataxia. These clinical signs were less severe than those
observed in rats receiving two exposures to 600 ppm. The
clinical conditions improved during the 14-day holding
period; however, several rats continued to exhibit ataxia
with head tilt.
Histopathology
No microscopic brain lesions were observed in rats
exposed to 75, 150, or 300 ppm COS for 4 days. Micro-
scopic evaluation of brain sections from rats exposed to 600
ppm COS for 1 day and held for 2 weeks included necrosis
and microgliosis in the cerebellar roof nucleus, internal
capsule, and thalamus (Table 1, Fig. 1). Also present was
vacuolation of the cerebellar medullary white matter and
fifth cranial nerve tract. Microscopic evaluation of brain
sections from moribund animals exposed to 600 ppm COS
for 2 days revealed extensive bilateral symmetrical necrosis
in parietal cortex area 1 and thalamus (Table 1, Fig. 2).
Necrosis was also observed in the retrosplenial granular
cortex, pyriform cortex, red nucleus, cerebellar roof nucleus,
posterior collicular nucleus, and anterior olivary nucleus.
Although the posterior colliculus is not typically examined
in standard brain survey sections, a fortuitous section in one
animal indicated severe necrosis. Based on this finding and
the consistent detection of hypointense areas (gliosis) in the
posterior colliculus by magnetic resonance microscopy
(MRM), in subsequent experiments, animals were examined
for midbrain lesions. No brain lesions were observed in
animals exposed to 75, 150, or 300 ppm COS for 6 h and
held for 2 weeks.
Two-week repeated exposure
Clinical observations
All male (10/10) and female (4/10) rats exposed to 500
ppm COS for 2 weeks were euthanized in moribund
condition and removed from the study. Male rats were
D.L. Morgan et al. / Toxicology and Applied
found moribund after 4 (1/10), 5 (6/10), and 10 (3/10)
exposures. Similarly, females were found moribund after 5
(2/10) and 11 (2/10) exposures. Moribund animals exhibited
clinical signs of hypothermia, lethargy, ataxia with poor
control of front and rear limbs. Rats exposed to 300 and 400
ppm COS exhibited no adverse clinical signs.
Body weights
Body weights of male and female rats receiving 12
exposures to 300 and 400 ppm COS were not significantly
different from controls (Table 2). Body weights of surviving
males and females in the 500 ppm exposure groups were
significantly less than controls (P<0.05) after five exposures.
Fig. 3. Brain from a female F344 rat exposed to (A) filtered air (control) or (B) 50
symmetrical malacia in the frontoparietal cortex (arrows). (C) In addition to the e
extensive malacia in the thalamus (arrows), H&E, 3.3�. (D) Necrosis of the retrosp
ppm COS, H&E, 13.2�.
Functional observational battery (FOB)
At 500 ppm, surviving females showed significantly
decreased grip strength (both forelimb and hindlimb), hypo-
tonia, and slight gait abnormalities. Similar but lesser effects
were seen at 400 ppm: slight gait changes in about half the
rats and hypotonia (both sexes). Both 300 and 400 ppm
produced slightly increased handling reactivity, but this effect
was transient and not clearly dose responsive. No changes in
activity levels or sensorimotor responses were detected.
Histopathology
Bilateral symmetrical malacia of the frontoparietal cor-
tex was observed upon gross examination of brains from
Pharmacology 200 (2004) 131–145 137
0 ppm COS for 5 days. Compared to the control, note the marked bilateral
xtensive malacia in the parietal cortex area 1 (arrowheads), note the locally
lenial cortex (arrows) was a common lesion observed in rats exposed to 500
D.L. Morgan et al. / Toxicology and Applied Pharmacology 200 (2004) 131–145138
rats exposed to 400 and 500 ppm COS for 2 weeks (Figs.
3B and 4A). Microscopic lesions were present in the brain
of all early death rats exposed to 500 ppm and in 8/10 male
and 9/10 female rats exposed to 400 ppm for 2 weeks
(Table 3). Brain lesions were present in one female exposed
to 300 ppm for 2 weeks. Predominant lesions in males and
females at both 500 and 400 ppm included bilateral
symmetrical necrosis in the parietal cortex area 1 (Fig.
3C) and putamen. At 500 ppm only, bilateral symmetrical
necrosis was present in the retrosplenial cortex (Fig. 3D),
thalamus, red nucleus, posterior colliculus, nucleus of
lateral lemniscus, anterior olivary nucleus, and vestibular
nucleus. In rats exposed to 500 ppm for 12 days, there was
loss of brain substance (cavitation) within the parietal
Fig. 4. Male F344 rats exposed to 500 ppm COS for 12 days. (A) Compared to Fi
rats exposed for a longer duration. (B) The depressed area (arrows) represents an
H&E, 3.3�. (C) Similar cavitation is observed in the retrosplenial cortex (arrow), H
and immature capillary reticulum (arrow) in the area of prior malacia (cavitation)
cortex (Figs. 4A–B) and retrosplenial cortex (Figs. 4C–
D) when compared to rats exposed to 500 ppm COS for 5
days.
Twelve-week study
There were no exposure-related deaths, morbidity, or
clinical signs of toxicity in male or female rats exposed
for 12 weeks to 200, 300, or 400 ppm COS.
Body weights
Body weights of male and female rats were not signif-
icantly different from controls (P > 0.05) throughout the 12-
week study (data not shown).
g. 3B, note the prominent depression of the frontoparietal cortex (arrows) in
area of prior malacia where there is loss of the brain substance (cavitation),
&E, 10�. (D) At a higher magnification, note the cavitation, macrophages,
in the retrosplenial cortex, H&E, 50�.
Table 3
Incidence of neuropathological lesions in rats exposed to COS for 2 weeks
CNS regiona Neuropathology lesion COS concentration (ppm)
Male Female
Control 300 400 500 Control 300 400 500
Brain lesion
Parietal cortex area 1 Cortical necrosis 0/10 0/10 5/10* 6/6** 0/10 1/10b 8/10** 10/10**
Retrosplenial cortex Cortical necrosis 0/10 0/10 0/10 4/6** 0/10 0/10 0/10 7/10**
Hippocampus CA1 and 3 Neuronal necrosis 0/10 0/10 1/10 0/6 0/10 0/10 1/10 3/10
Putamen Necrosis 0/10 0/10 5/10* 6/6** 0/10 0/10 6/10** 8/9**
Thalamus Necrosis or vacuolation 0/10 0/10 0/10 2/6 0/10 0/10 0/10 6/10**
Red nucleus Necrosis 0/8 0/9 0/10 3/6 0/10 0/9 0/8 3/8
Posterior colliculus Necrosis 0/10 0/10 2/7 3/3** 0/8 0/0 3/9 8/10**
Anterior olivary nucleus Necrosis 0/10 0/10 0/10 5/6** 0/10 0/10 0/10 6/10**
Vestibular nucleus Necrosis 0/10 0/10 0/10 2/4 0/10 0/10 0/10 1/10
Fifth cranial nerve tract Vacuolation 0/10 0/10 0/10 1/6 0/10 0/10 0/10 0/10
Nucleus lateral lemniscus Necrosis 0/10 0/0 0/0 0/0 0/0 0/0 0/0 3/5
Some animals in the 500 ppm groups became moribund and were euthanized early.a Thirty-four specific named areas of brain were recorded in the data sheets of six standard sections of the brain.b Number of animals with the lesion/number of animals for which that area of brain was examined.
*P < 0.05 vs. controls (Fisher’s exact test).
Table 4
COS exposure inhibits cytochrome oxidase (CO) activity in posterior
colliculus of rat brain
COS Female Male
(ppm)CO activitya Percentage
of control
Co activitya Percentage
of control
Day 24
0 1792 F 272b 100 1919 F 192 100
200 1477 F 281* 82 1735 F 97 90
300 1389 F 217** 78 1791 F 223 90
400 1300 F 208** 72 1676 F 202* 87
Day 52
0 1633 F 337 100 1596 F 238 100
200 1253 F 271** 77 1421 F 298 89
300 998 F 102** 61 763 F 139** 48
400 1208 F 276** 74 739 F 103** 46
Day 86
0 1931 F 265 100 1788 F 94 100
200 1607 F 167** 83 1533 F 128** 86
300 1330 F 93** 69 1283 F 106** 72
400 1249 F 219** 65 1241 F 123** 69
a Amol/min/mg/protein.b Means F SD (10).
*P < 0.05 vs. control (Dunnett’s test).
**P < 0.001 vs. control (Dunnett’s test).
D.L. Morgan et al. / Toxicology and Applied Pharmacology 200 (2004) 131–145 139
Clinical pathology
Serum chemistry measurements were evaluated after
exposure of rats for 12 weeks. Statistically significant
(P < 0.05) chemical-related changes were observed in
several serum chemistry parameters in male rats only.
Serum ALP, cholesterol, SDH, protein, and creatinine
were all significantly decreased in COS-exposed male
rats relative to controls; however, the biological signifi-
cance of these mild, negative changes is not clear (data
not shown).
Brain cytochrome oxidase activity
A concentration-related decrease in cytochrome oxidase
activity was detected in the posterior colliculus (Table 4)
and parietal cortex (Table 5) of male and female rats
exposed to COS for 3, 6, and 12 weeks. These significant
decreases (P < 0.05) in cytochrome oxidase activity were
present in the brain of rats exposed to 200 and 300 ppm
where no histopathological findings were present. No gen-
der-related differences in cytochrome oxidase activity were
apparent except at day 52. Cytochrome oxidase activity was
decreased to less than 50% of controls in male rats at day
52; however, animals appeared to be recovering by the 86-
day time point.
Functional observational battery
Mild gait changes were observed in only about a fourth
of the rats, and this was somewhat more prevalent at 6
weeks compared to 12 weeks. All exposed males displayed
decreased handling reactivity, but only at 6 weeks. Increased
arousal was also observed in both sexes, but this was not
consistent with respect to dose or sex. Female rats in the low
dose group only showed a decreased response to the click
stimulus. Unlike the 2-week study, grip strength changes
and hypotonia were not observed.
**P < 0.001 vs. controls (Fisher’s exact test).
Histopathology
Microscopically at 12 weeks, neuropathological findings
were only present in male and female rats exposed to 400
ppm COS (Table 6). Predominant findings included unilat-
eral and bilateral symmetrical cortical necrosis and cavita-
tion in the parietal cortex area 1 (Figs. 5A–D), and bilateral
symmetrical neuronal loss with microgliosis and sometimes
hemorrhage in the posterior colliculus (Figs. 5E–F). Occa-
Table 5
COS exposure inhibits cytochrome oxidase (CO) activity in parietal cortex
of rat brain
COS Female Male
(ppm)CO activitya Percentage
of control
CO activitya Percentage
of control
Day 24
0 1829 F 163b 100 1841 F 170 100
200 1642 F 88** 90 1580 F 204* 86
300 1129 F 127** 62 1258 F 190** 68
400 1182 F 104** 65 1066 F 234** 58
Day 52
0 2131 F 257 100 1898 F 334 100
200 1629 F 209** 76 1755 F 139 92
300 1171 F 232** 55 1277 F 108** 67
400 1227 F 139** 58 1227 F 94** 65
Day 86
0 1711 F 125 100 1687 F 214 100
200 1268 F 232** 74 1349 F 111** 80
300 928 F 175** 54 816 F 129** 48
400 857 F 72** 50 935 F 185** 55
a Amol/min/mg/protein.b Means F SD (10).
*P < 0.05 vs. control (Dunnett’s test).
**P < 0.001 vs. control (Dunnett’s test).
Table 6
Incidence of neuropathological lesions in rats exposed to COS for 12 weeks
CNS regiona Neuropathology COS concentration (ppm)
lesionControl 300 400
Parietal
cortex area 1
Cortical necrosis
or cavitation
0/10b 0/10 5/10*
Putamen Necrosis or
cavitation
0/10 0/10 2/10
Thalamus Necrosis 0/10 0/10 1/10
Posterior
colliculus
Neuronal loss or
microgliosis
0/9 0/9 7/9**
Posterior colliculus Hemorrhage 0/9 0/9 2/9
Lat. anterior
olivary nucleus
Neuronal loss or
microgliosis
0/10 0/9 1/10
Parietal cortex area 1 Cortical necrosis 0/10c 0/10 4/10*
Putamen Necrosis 0/10 0/10 0/10
Thalamus Necrosis 0/10 0/10 0/10
Posterior colliculus Neuronal loss or
microgliosis
0/9 0/9 5/9**
Posterior colliculus Hemorrhage 0/9 0/9 1/9
Lat. anterior
olivary nucleus
Neuronal loss or
microgliosis
0/9 0/10 0/9
a Thirty-six specific-named areas of brain were recorded in the data sheets
of six standard sections of brain.b Number of male rats with the lesion/number for animals for which that
area of brain was examined.c Number of female rats with the lesion/number of animals for which that
area of brain was examined.
*P < 0.05 vs. controls (Fishers exact test).
**P < 0.001 vs. control (Fisher’s exact test).
D.L. Morgan et al. / Toxicology and Applied Pharmacology 200 (2004) 131–145140
sionally, necrosis was present in the putamen, thalamus, and
anterior olivary nucleus of male rats.
Brainstem auditory evoked responses
Exposure to 400 ppm COS for 2 weeks altered the
BAER waveforms relative to air-exposed controls (Fig. 6).
Changes in peak amplitudes were observed in the portion
of the waveforms associated with auditory transmission in
the brainstem. The most striking change was the reduction
in positive voltage associated with peak P4 (F[1,18] = 9.43,
P = 0.0066) and the reduced negative voltage associated
with peak N5 (F[1,18] = 5.43, P = 0.0316). The reduction
in positive voltage at the time of peaks N3 (F[1,18] =
16.79, P = 0.0007) and N4 (F[1,18] = 8.42, P = 0.0095)
resulted in a larger negative response in treated animals
(Fig. 7).
Changes in the latencies of BAER peaks were less
dramatic than changes in peak amplitudes. Increases in the
latencies of peaks P2 (F[1,18] = 4.56, P = 0.0467), N3
(F[1,18] = 17.08, P = 0.0006), P4 (F[1,18] = 5.40, P =
0.0320), N4 (F[1,18] = 5.27, P = 0.0339), and P5 (F[1,18] =
8.42, P = 0.0095) were observed (Fig. 7).
Exposure to 400 ppm COS produced only minor changes
in the animal’s general health status. No changes in colonic
temperature (F[1,18] = 0.90, P = 0.3559) were observed.
The colonic temperatures were 39.0 F 0.1 and 38.7 F 0.3
jC for the control and 400 ppm animals, respectively.
Magnetic resonance microscopy (MRM)
The incorporation of magnetic resonance microscopy
(MRM) in this study allowed the identification of signif-
icant lesions that would have been missed with standard
histological evaluation of three brain sections (Sills et al.,
2004). In the initial range-finding study, three standard
brain sections were evaluated from each animal, and
functional sites associated with the auditory system were
identified as potential targets of COS neurotoxicity. Be-
cause the posterior colliculus of only one animal was
examined, it was not apparent that this site was a signif-
icant target of COS toxicity. However, after conducting
parallel studies and evaluating the entire brain by MRM, it
became clear that the posterior colliculus was indeed a
primary target (Fig. 8). After evaluating the MRM data,
the fixed tissues were sectioned to include the posterior
colliculus and this site was confirmed by light microscopy
to be a consistent site of neurotoxicity.
Discussion
The brain has been reported to be the major target organ
in acute inhalation toxicity studies of COS in rats (Mon-
santo, 1985; Nutt et al., 1996). The current study examined
in greater detail the distribution of lesions in the brain
following COS exposure for up to 12 weeks using standard
histopathology and MRM (Sills et al., 2004). The target
sites observed were dependent upon the COS concentration
and duration of exposure. Acute exposures of rats to 600
Fig. 5. Female F344 rats exposed to 400 ppm COS for 12 weeks. (A) The MRM image shows a unilateral hypointense area (arrow) in parietal cortex area 1. (B)
Matching H&E section showing an area of neuronal loss (arrow), 2.5�. (C) Higher magnification (25�) of (B) showing complete loss of the grey matter with
only a gliovascular reticulum remaining (arrow) in an area of prior malacia. (D) Note here in another example the bilateral symmetrical loss of brain substance
in an area of prior malacia in the parietal cortex area 1 (arrows; 2.5�). (E) In the posterior colliculus, there is bilateral symmetrical loss of neurons and
infiltration of the affected regions by reactive glial cells (arrows), H&E; 5�. (F) High magnification of (E) (50�) showing the loss of neurons. The area of
necrosis is infiltrated with glial cells and occasional microglial cells containing hemosiderin (arrows).
D.L. Morgan et al. / Toxicology and Applied Pharmacology 200 (2004) 131–145 141
ppm COS for 1 day and held for 2 weeks caused necrosis
predominantly in functional areas associated with move-
ment such as the cerebellum and associated tracts. Consis-
tent with these findings, the exposed rats showed motor
dysfunction including ataxia and head tilt. With longer
exposure to 600 ppm (2 days), consistent neurotoxicity
was seen in parietal cortex area 1, thalamus, posterior
colliculus, anterior olivary nucleus, and cerebellar roof
nucleus. Lesions observed during 2 weeks of COS exposure
to 500 ppm, but not to 400 ppm, included necrosis in the
retrosplenial cortex, thalamus, red nucleus, anterior olivary
nucleus, and nucleus of the lateral lemniscus. After 12
weeks of exposure to 400 ppm, necrosis was identified in
parietal cortex area 1, the posterior colliculus, and to a lesser
extent in the putamen, thalamus, and anterior olivary nu-
cleus. High exposure concentrations (400 and 500 ppm)
produced motor dysfunction in rats, but following lower
concentrations (200 and 300 ppm), there was no clear
pattern of neurobehavioral changes. Compensation of these
behavioral effects was apparent at high concentrations, since
effects after 2 weeks of exposure to 400 ppm were greater
than after 6 or 12 weeks at the same concentration.
Carbonyl sulfide first caused necrosis of neurons fol-
lowed by neuronal loss with some cavitation and collapse of
the brain tissue. In affected areas, there was spongiosis of
the residual neuropil and the presence of hemosiderin-laden
macrophages. Additionally, there was a reactive astrocytic
reticulum and proliferation of capillaries in areas of prior
necrosis. For the most part, even with repeated COS
exposures, these lesions appeared to develop early and there
Fig. 6. Average BAER waveforms following stimulation with an 80 dB
SPL rarefaction click for rats exposed to 0 or 400 ppm COS (n = 10 per
group) for 2 weeks. Waveforms are plotted with positivity upward. The
shaded and crosshatched regions represent the 95% amplitude confidence
intervals for the waveforms from 0 and 400 ppm COS rats, respectively (see
text for details).
D.L. Morgan et al. / Toxicology and Applied Pharmacology 200 (2004) 131–145142
was no evidence of later sequential development of new
lesions. These results suggest that vulnerable sites were
affected early and unaffected areas of brain may be refrac-
tory to lesions by this compound.
The distribution of lesions within the brain may be
multifactorial and a reflection of function, regional metabolic
and biochemical differences, and possibly blood supply
(Cavanagh, 1988; Cremer et al., 1983). The major sites of
COS toxicity were associated with key CNS functions; the
parietal cortex area 1 is associated with somatosensory
function particularly of the vibrissae, face, and forelimbs,
the thalamus is the main sensory relay to cortical areas, the
retrosplenial cortex is associated with limbic function, and
the anterior olivary nucleus, lateral lemniscus, and posterior
colliculus are linked to function of binaural sound localiza-
tion and reflexes, respectively (Paxinos, 1995). Corres-
ponding to its functional role, the posterior colliculus is
Fig. 7. Amplitudes and latencies of BAER peaks (FSE) were affected by exposure
COS reduced the positive voltage associated with peaks N3, P4, and N4, and red
increased peak latencies (see text for details). *P < 0.05, significantly different fr
one of the most metabolically active areas in the brain and
has the largest microvascular blood volume (Cremer et al.,
1983; Scremin, 1985), the highest rate of blood flow (Sakur-
ada et al., 1978), and the highest rate of glucose metabolism
(Sokoloff, 1981; Sokoloff et al., 1977). The posterior colli-
culus may be the most metabolically active area in the brain
because auditory processing is continuous (Faingold et al.,
1991; Webster, 1995). Because of their acute hearing capac-
ity, rodents tend to show lesions in the posterior colliculus
but not in the superior colliculus due to the relative impor-
tance of auditory vs. visual sensory processing.
In this study, exposure to 400 ppm COS for 2 weeks
resulted in functional changes in auditory processing at the
level of the brainstem. Peaks of the BAER are believed to
be generated in the following region(s): peak P1 by the
auditory nerve, peak P2 at the level of the cochlear nucleus,
peak P3 in the region of the olivary complex, peak P4 in the
region of the lateral lemniscus, peak P5 in the brainstem
and posterior colliculus, and P6 in the brainstem and medial
geniculate nucleus (Chen and Chen, 1991; Melcher et al.,
1996; Moller and Jannetta, 1986; Shaw, 1988; Zaaroor and
Starr, 1991). The observed decrease in peak P4 amplitude is
consistent with a lesion in the region of the olivary
complex–lateral lemniscus region of the brainstem. Of
interest is the general decrease in positivity over the N3–
P5 region and the reduction in negativity over the N5–P6region of the BAER waveforms (Fig. 6). Reducing the high
frequency content of BAER waveforms using filters yields
a slow positive (SP3) and slow negative (SN5) waveform
during these portions of the BAER (Shaw, 1987). The SP3
wave has been proposed to arise from activity in the lateral
lemniscus or the posterior colliculus (Hashimoto et al.,
1981; Moller and Jannetta, 1982) while the SN5 is believed
to be generated at the level of the posterior colliculus
(Hashimoto, 1982; Hashimoto et al., 1981; Funai and
to 400 ppm COS for 2 weeks. Peaks are labeled as in Fig. 6. Treatment with
uced the negative voltage associated with peak N5. Exposure to COS also
om 0 ppm control.
Fig. 8. Female F344 rat exposed to 400 ppm COS for 8 weeks. (A) MRM of whole brain (3D Image) showing the area of the brain that corresponds to the
posterior colliculus (red line). Also, note the hyperintense areas in the parietal cortex area 1 representing areas of malacia (arrows). (B) Sagittal slice through the
posterior colliculus showing a hypointense locally extensive lesion (arrow). (C) The corresponding transverse slice shows the hypointense area (arrow). (D)
Correlation of the MRM image with an H&E section confirms that the unilateral hypointense area represented a prior area of hemorrhage. The posterior
colliculus nucleus is replaced by numerous hemosiderin laden macrophages (black focal area—arrow), H&E, 2.5�.
D.L. Morgan et al. / Toxicology and Applied Pharmacology 200 (2004) 131–145 143
Funasaka, 1983; Moller and Jannetta, 1982). While these
waves were not specifically quantified in this study, the
observed changes in the BAER waveforms are consistent
with alterations in these regions of the brainstem. There-
fore, the alterations in BAERs indicate that treatment with
COS produced changes in brainstem processing of the click
stimulus from the region of the olivary nucleus to the
posterior colliculus.
The increases in BAER peak latencies were less dramatic
than the alterations in peak amplitudes. Treatment with COS
did not alter colonic temperature. Therefore, the increases in
peak latencies were not attributable to temperature-related
effects. Changes in peak latency may be the result of
alterations in waveform shape, a change in the size distri-
bution of the axons contributing to the evoked response, or
damage to the myelin (Mattsson et al., 1992). In view of the
neuronal damage in the brainstem produced by treatment
with COS, several of the above factors could contribute to
the observed increases in BAER peak latencies. Because the
affected peaks were related to brainstem generators, a
general effect by COS on myelin is unlikely (e.g., peak P1[auditory nerve] was not affected). A more complete exam-
ination of auditory electrophysiology following treatment
with COS is forthcoming and will allow replication of the
changes reported in this study.
The mechanism(s) for COS neurotoxicity is unknown.
However, in initial acute COS exposures (Nutt et al.,
1996), elevated oxyhemoglobin levels were observed in
COS exposed rats, and it was hypothesized that COS
inhibited mitochondrial respiration. Others (Chengelis and
Neal, 1980) proposed that COS is initially metabolized by
carbonic anhydrase to hydrogen sulfide (H2S), and in
subsequent studies H2S was shown to inhibit brain cyto-
chrome oxidase (Dorman et al., 2002; Khan et al., 1990;
Nicholls and Kim, 1982). Cytochrome oxidase is a rate-
limiting enzyme in the mitochondrial respiratory chain
(oxidative phosphorylation) (Nicklas et al., 1992). In
COS-exposed rats, decreases in mitochondrial cytochrome
oxidase activity were detected in the frontoparietal cortex
and posterior colliculus. Although these results suggest
that inhibition of oxidative phosphorylation may contribute
to neuronal cell death, further research is needed. These
cumulative data suggest that COS inhalation may cause
neurotoxicity by a mechanism involving inhibition of brain
cytochrome oxidase, resulting in decreased ATP production
and neuronal cell death. The ability of COS to react
D.L. Morgan et al. / Toxicology and Applied Pharmacology 200 (2004) 131–145144
directly with critical target sites in the brain is not known;
however, H2S and the hydrosulfide anion (HS�) are
potential metabolites of COS (Chengelis and Neal, 1980)
and are potent inhibitors of cytochrome oxidase (Holland
and Kozlowski, 1986; Smith et al., 1977). Additional
research is needed to investigate the potential role of
H2S in COS neurotoxicity.
The distribution of brain lesions caused by COS is
similar to that described for other chemicals known to
target the mitochondrial respiratory pathway (Cavanagh,
1988, 1993). These vulnerable areas of the brain all have
relatively high resting glucose utilization rates (Bagley et
al., 1989; Sokoloff, 1981; Sokoloff et al., 1977). Exposure
to 1,3-dinitrobenzene (DNB), a commonly used industrial
chemical, caused lesions similar to those of COS in the
anterior olivary nuclei, posterior colliculus, and cerebellar
nucleus by a mechanism that inhibits oxidative phosphor-
ylation (Philbert et al., 1987; Ray et al., 1992). Chlorohy-
drin also caused similar lesions at sites in the brain that
have high-energy requirements (Cavanagh and Nolan,
1993; Cavanagh et al., 1993).
In conclusion, inhalation exposure to COS at concen-
trations of 400 ppm and above resulted in marked neuro-
toxicity. Carbonyl sulfide targeted specific neuroanatomical
sites in the auditory system that correlated with alterations
in the amplitude of BAER between the anterior olivary
nucleus to the medial geniculate nucleus. The higher the
exposure concentration, the more striking and widespread
were the neuropathological effects as well as the neuro-
behavioral effects. Our data suggest that decreases in
cytochrome oxidase in exposed rats may be involved in
the pathogenesis of neuronal injury. Neuropathological
findings were not present at lower COS concentrations
(200 and 300 ppm), and no clear behavioral changes were
observed. Cytochrome oxidase activity was decreased at the
lower concentrations; however, not to a point where cell
death occurred.
Acknowledgments
The ManTech Environmental Technology, Inc. personnel
are acknowledged for their expertise in conducting the
inhalation exposures. Drs. Fletcher Hahn and Janet Benson
are thanked for useful discussions and for providing data
from the initial COS studies conducted at Lovelace
Respiratory Research Institute. Dr. Connie Cummings of
Pathology Associates, Division of Charles Rivers is
recognized for her superior coordination of the cardiac
perfusion team. The authors also wish to thank Drs. Irwin
and Boyes for their crucial review of the manuscript, Ms.
Jaimie Graff and Pamela Phillips for excellent technical
support in the BAER testing and neurobehavioral testing,
respectively, and Mr. C. Hamm for the design and
implementation of the software used for electrophysiolog-
ical recordings.
The information in this document has been funded in part
by the U.S. Environmental Protection Agency. It has been
subjected to review by the National Health and Environmen-
tal Effects Research Laboratory and approved for publication.
References
Bagley, P.R., Tucker, S.P., Nolan, C., Lindsay, J.G., Davies, A., Baldwin,
S.A., Cremer, J.E., Cunningham, V.J., 1989. Anatomical mapping of
glucose transporter protein and pyruvate dehydrogenase in rat brain: an
immunogold study. Brain Res. 499, 214–224.
Beauchamp, R.O., Bus, J.S., Popp, J.A., Boreiko, C.J., Golberg, L., 1983.
A critical review of the literature on carbon disulfide toxicity. CRC Crit.
Rev. Toxicol. 11, 169–278.
Cavanagh, J.B., 1988. Lesion localization: implications for the study of
functional effects and mechanisms of action. Toxicology 49, 131–136.
Cavanagh, J.B., 1993. Selective vulnerability in acute energy deprivation
syndromes. Neuropathol. Appl. Neurobiol. 19, 461–470.
Cavanagh, J.B., Nolan, C.C., 1993. The neurotoxicity of alpha-chlorohy-
drin in rats and mice: II. Lesion topography and factors in selective
vulnerability in acute energy deprivation syndromes. Neuropathol.
Appl. Neurobiol. 19, 471–479.
Cavanagh, J.B., Nolan, C.C., Seville, M.P., 1993. The neurotoxicity of
alpha-chlorohydrine in rats and mice: I. Evolution of the cellular
changes. Neuropathol. Appl. Neurobiol. 19, 240–252.
Chen, T.J., Chen, S.S., 1991. Generator study of brainstem auditory evoked
potentials by a radiofrequency lesion method in rats. Exp. Brain Res.
85, 537–542.
Chengelis, C.P., Neal, R.A., 1980. Studies of carbonyl sulfide toxicity:
metabolism by carbonic anhydrase. Toxicol. Appl. Pharmacol. 55,
198–202.
Cremer, J.E., Cunningham, V.J., Seville, M.P., 1983. Relationships be-
tween the extraction and metabolism of glucose, blood flow and tissue
blood volume in regions of rat brain. J. Cereb. Blood Flow Metab. 3,
291–302.
de Jesus, P.V.J., Hausmanowa-Petrusewicz, I., Barchi, R.L., 1973. The
effect of cold on nerve conduction of human slow and fast nerve fibers.
Neurology 23, 1182–1187.
Dorman, D.C., Moulin, F.J.-M., McManus, B.E., Mahle, K.C., James,
R.A., Struve, M.F., 2002. Cytochrome oxidase inhibition induced by
acute hydrogen sulfide inhalation: correlation with tissue sulfide con-
centrations in the rat brain, liver, lung, and nasal epithelium. Toxicol.
Sci. 65, 18–25.
EPA R.A., 1994. Integrated Risk Information System (IRIS) Online. Office
of Health and Environmental Assessment, Cincinnati, OH.
Faingold, C.L., Gehlbach, G., Caspary, D.M., 1991. Functional pharma-
cology of inferior colliculus neurons. In: Altschuler, R.A.e.a. (Ed.),
Neurobiology of Hearing: The Central Auditory System. Raven Press,
Ltd., New York, pp. 223–252.
Funai, H., Funasaka, S., 1983. Experimental study on the effect of infe-
rior colliculus lesions upon auditory brainstem response. Audiology
22, 9–19.
Hall, J.W., 1992. Handbook of Auditory Evoked Responses. Allyn and
Bacon, Boston, MA.
Hamm, C.W., Ali, J.S., Herr, D.W., 2000. A system for simultaneous
multiple subject, multi stimulus modality, and multiple channel collec-
tion and analysis of sensory evoked potentials. J. Neurosci. Methods
102, 95–108.
Hashimoto, I., 1982. Auditory evoked potentials from the human midbrain:
slow brain responses. Clin. Neurophysiol. 53, 652–657.
Hashimoto, I., Ishiyama, Y., Yoshimoto, T., Nemoto, S., 1981. Brain stem
auditory-evoked potentials recorded directly from human brain-stem
and thalamus. Brain 104, 841–859.
Herr, D.W., Boyes, W.K., 1997. A comparison of the acute neuroactive
D.L. Morgan et al. / Toxicology and Applied Pharmacology 200 (2004) 131–145 145
effects of dichloromethane, 1,3-dichloropropane, and 1,2-dichloroben-
zene on rat flash evoked potentials (FEPs). Fundam. Appl. Toxicol. 35,
31–48.
Herr, D.W., Boyes, W.K., Dyer, R.S., 1992. Alterations in rat flash and
pattern reversal evoked potentials after acute or repeated administration
of carbon disulfide (CS2). Fundam. Appl. Toxicol. 18, 328–342.
Herr, D.W., King, D., Griffin, V.T., Watkinson, W.P., Boyes, W.K., Ali,
J.S., Dyer, R.S., 1994. Within-session changes in peak N160 amplitude
of flash evoked potentials in rats. Physiol. Behav. 55, 83–99.
Herr, D.W., Goldey, E.S., Crofton, K.M., 1996. Developmental expo-
sure to aroclor 1254 produces low-frequency alterations in adult rat
brainstem auditory evoked responses. Fundam. Appl. Toxicol. 33,
120–128.
Hess H.H., Pope A., 1963. Quantitative Chemical Techniques of Histo- and
Cytochemistry. Wiley, New York.
Hetzler, B.E., Dyer, R.S., 1984. Contribution of hypothermia to effects of
choral hydrate on flash evoked potentials of hooded rats. Pharmacol.
Biochem. Behav. 21, 599–607.
Hetzler, B.E., Boyes, W.K., Creason, J.P., Dyer, R.S., 1988. Temperature-
dependent changes in visual evoked potentials of rats. Electroencepha-
logr. Clin. Neurophysiol. 70, 137–154.
Holland, M.A., Kozlowski, L.M., 1986. Clinical features and management
of cyanide poisoning. Clin. Pharm. 5, 737–741.
Houben-Weyl, 1955. Methoden der Anorganischen Chemie.4. Aufl.,
Schwefel-, Selen-, Tellur-Verbindungen, S. 781–783.
Janssen, R., Hetzler, B.E., Creason, J.P., Dyer, R.S., 1991. Differential
impact of hypothermia and pentobarbital on brain-stem auditory
evoked responses. Electroencephalogr. Clin. Neurophysiol. 80,
412–421.
Johnson, G.A., Cofer, G.P., Fubara, B., Gewalt, S.L., Hedlund, L.W., Mar-
onpot, R.R., 2002. Magnetic resonance histology for morphologic phe-
notyping. J. Magn. Reson. Imaging 16, 423–429.
Khan, A.A., Schuler, M.M., Prior, M.G., Yong, S., Coppock, R.W., Flor-
ence, L.Z., Lillie, L.E., 1990. Effects of hydrogen sulfide exposure on
lung mitochondrial respiratory chain enzymes in rats. Toxicol. Appl.
Pharmacol. 103, 482–490.
Mattsson, J.L., Boyes, W.K., Ross, J.F., 1992. Incorporating evoked poten-
tials into neurotoxicity test schemes. In: Tilson, H., Mitchell, C. (Eds.),
Neurotoxicology. Raven Press Ltd., New York, pp. 125–145.
McDaniel, K.L., Moser, V.C., 1993. Utility of a neurobehavioral screening
battery for differentiating the effects of two pyrethroids, permethrin and
cypermethrin. Neurotoxicol. Teratol. 15, 71–83.
McDowell, E.M., Trump, B.F., 1976. Histological fixatives suitable for
diagnostic light and electron microscopy. Arch. Pathol. Lab. Med.
100, 405–414.
Melcher, J.R., Guinan, J.J.J., Knudson, I.M., Kiang, N.Y., 1996. Generators
of the brainstem auditory evoked potential in cat: II. Correlating lesion
sites with waveform changes. Hear. Res. 93, 28–51.
Miyoshi, T., Goto, I., 1973. Serial in vivo determinations of nerve conduc-
tion velocity in rat tails. Physiological and pathological changes. Elec-
troencephalogr. Clin. Neurophysiol. 35, 125–131.
Moller, A.R., Jannetta, P.J., 1982. Evoked potentials from the inferior colli-
culus in man. Electroencephalogr. Clin. Neurophysiol. 53, 612–620.
Moller, A.R., Jannetta, P.J., 1986. Simultaneous surface and direct brain-
stem recordings of brainstem auditory evoked potentials (BAEP) in
man. In: Cracco, R.Q., Bodis-Wollner, I. (Eds.), Evoked Potentials.
Alan R. Liss Inc., New York, pp. 227–234.
Monsanto, 1985. Acute inhalation toxicity of carbon oxysulfide to
Sprague–Dawley rats. Microfiche Number OTS0534820, Washington,
DC, OPPT, US EPA (1991).
Nicholls, P., Kim, J.K., 1982. Sulphide as an inhibitor and electron
donor for the cytochrome c oxidase system. Can. J. Biochem. 60,
613–623.
Nicklas, W.J., Saporito, M., Basma, A., Geller, H.M., Heikkila, R.E., 1992.
Mitochondrial mechanisms of neurotoxicity. Ann. N. Y. Acad. Sci. 648,
28–36.
Nutt, A.W., Benson, J.M., Barr, E.B., Burt, D.G., Hahn, F.F., Lewis, J.L.,
Dahl, A.R., 1996. Acute inhalation toxicity of carbonyl sulfide. Soc.
Toxicol. Proc. 18.
Paxinos, G. (Ed.), 1995. The Rat Nervous System. Academic Press,
San Diego.
Petajan, J.H., 1968. Changes in rat ventral caudal nerve conduction velocity
during cold exposure. Am. J. Physiol. 214, 130–132.
Philbert, M.A., Nolan, C.C., Cremer, J.E., Tucker, D., Brown, A.W., 1987.
1,3-Dinitrobenzene-induced encephalopathy in rats. Neuropathol. Appl.
Neurobiol. 1987, 371–389.
Ray, D.E., Brown, A.W., Cavanagh, J.B., Nolan, C.C., Richards, H.K.,
Wylie, S.P., 1992. Functional/metabolic modulation of the brain stem
lesions caused by 1,3-dinitrobenzene in the rat. Neurotoxicology 13,
379–382.
Sakurada, O., Kennedy, C., Jehle, J., Brown, J.D., Carbin, G., Sokoloff, L.,
1978. Measurement of local cerebral blood flow with iodo[14C]anti-
pyrine. Am. J. Physiol. 234, H59–H66.
SAS Institute L., 1989. SAS/STAT User’s Guide. SAS Institute Inc, Cary,
NC.
SAS Institute L., 1997. SAS/STAT Software: Changes and Enhancements
Through Release. SAS Institute Inc, Cary, NC.
Scremin, O.U., 1985. Cerebral vascular system. In: Paxinos, G. (Ed.), The
Rat Nervous System. Academic Press, San Diego, pp. 3–35.
Shaw, N.A., 1987. Effects of low pass filtering on the brainstem auditory
evoked potential in the rat. Exp. Brain Res. 65, 686–690.
Shaw, N.A., 1988. The auditory evoked potential in the rat—A review.
Prog. Neurobiol. 31, 19–45.
Sills, R.C., Morgan, D.L., Herr, D.W., Little, P.B., George, N.M., Ton,
T.V., Love, N.E., Maronpot, R.R., Johnson, G.A., 2004. Contribution
of magnetic resonance microscopy in the 12-week neurotoxicity
evaluation of carbonyl sulfide in Fischer 344 rats. Toxicol. Pathol.
32 (to appear).
Smith, L., Kruszyna, H., Smith, R.P., 1977. The effect of methemoglobin
on the inhibition of cytochrome c oxidase by cyanide, sulfide, or azide.
Biochem. Pharmacol. 26, 2247–2250.
Sokoloff, L., 1981. Localization of functional activity in the central nervous
system by measurement of glucose utilization with radioactive deoxy-
glucose. J. Cereb. Blood Flow Metab. 36, 7–36.
Sokoloff, L., Reivicii, M., Kennedy, C., Des Rosiers, M.H., Patlak, C.S.,
Pettigrew, K.D., Sakurada, O., Shinohara, M., 1977. The [14C]deoxy-
glucose method for the measurement of local cerebral glucose utiliza-
tion: theory, procedure, and normal values in the conscious and
anesthetized albino rat. J. Neurochem. 28, 897–916.
Webster, W.R., 1995. Auditory system. In: Paxinos, G. (Ed.), The Rat
Nervous System. Academic Press, San Diego, pp. 797–831.
Wynder, E.L., Hoffmann, D., 1967. Tobacco and tobacco smoke. Studies in
Experimental Carcinogenesis. Academic Press, New York.
Zaaroor, M., Starr, A., 1991. Auditory brain-stem evoked potentials in cat
after kainic acid induced neuronal loss: I. Superior olivary complex.
Electroencephalogr. Clin. Neurophysiol. 80, 422–435.